Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1435)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3390)
  2. Solid Tumor Oncology Division (3390)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (636)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (110)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (702)
  2. Journal of Thoracic Oncology (515)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (781)
  2. Elsevier Inc. (736)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3390)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Assessing changes in tumor size with CT scans in lung cancer: Are volumetric measurements better than unidimensional (1D) and bidimensional (2D) assessments?
    Meeting Abstract

    Pietanza, M.; James, L. P.; Schwartz, L. H.; Ginsberg, M. S.; Zhao, B.; Moskowitz, C. S.; Zheng, J.; Rizvi, N. A.; Kris, M. G.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Acquired resistance to epidermal growth factor receptor (EGFR) kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Bean, J.; Riely, G. J.; Balak, M.; Marks, J. L.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Lack of efficacy of erlotinib in most EGFR mutated non-small cell lung cancers (NSCLCs) with acquired resistance to gefitinib
    Meeting Abstract

    Costa, D. B.; Cho, B. C.; Sequist, L. V.; Riely, G. J.; Halmos, B.; Kim, J.; Huberman, M. S.; Pao, W.; Tenen, D. G.; Kobayashi, S.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Comparison of patterns of relapse in thymic carcinoma and thymoma
    Meeting Abstract

    Huang, J.; Rizk, N.; Travis, W.; Riely, G. J.; Park, B. J.; Bains, M. S.; Flores, R. M.; Downey, R. J.; Rusch, V. W.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Patterns of co-expression of ERCC1 and p27 in resected non-small cell lung cancer by immunohistochemistry
    Meeting Abstract

    Rekhtman, N.; Azzoli, C. G.; Kris, M. G.; Park, B. J.; Zakowski, M. F.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Reproducibility of computed tomography (CT) measurements of lung cancer
    Meeting Abstract

    James, L. P.; Zhao, B.; Moskowitz, C. S.; Riely, G. J.; Miller, V. A.; Guo, P.; Ginsberg, M. S.; Kris, M. G.; Schwartz, L. H.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma
    Meeting Abstract

    Riely, G. J.; Kris, M. G.; Marks, J. L.; Li, A.; Chitale, D. A.; Riedel, E. R.; Hsu, M.; Pao, W.; Miller, V. A.; Ladanyi, M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Does CTCAE toxicity symptom reporting by patients or clinicians predict clinical outcomes?
    Meeting Abstract

    Basch, E. M.; Jia, X.; Barz, A.; Heller, G.; Culkin, A.; Appawu, M.; Barnett, T.; Jason, F.; Kris, M. G.; Schrag, D.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Reflex testing of lung adenocarcinomas for EGFR and KRAS mutations: The Memorial Sloan-Kettering experience
    Meeting Abstract

    Zakowski, M. F.; Ladanyi, M.; Rekhtman, N.; Park, B. J.; Finley, D.; Azzoli, C. G.; Riely, G. J.; Rusch, V. W.; Kris, M. G.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Activity of XL647 in clinically selected NSCLC patients (pts) enriched for the presence of EGFR mutations: Results from Phase 2
    Meeting Abstract

    Rizvi, N. A.; Kris, M. G.; Miller, V. A.; Krug, L. M.; Bekele, S.; Dowlati, A.; Rowland, K. M.; Salgia, R.; Aggarwal, N.; Gadgeel, S. M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save